+

AU2002367431A1 - Drugs against obeisty and drugs against fatty liver - Google Patents

Drugs against obeisty and drugs against fatty liver

Info

Publication number
AU2002367431A1
AU2002367431A1 AU2002367431A AU2002367431A AU2002367431A1 AU 2002367431 A1 AU2002367431 A1 AU 2002367431A1 AU 2002367431 A AU2002367431 A AU 2002367431A AU 2002367431 A AU2002367431 A AU 2002367431A AU 2002367431 A1 AU2002367431 A1 AU 2002367431A1
Authority
AU
Australia
Prior art keywords
drugs against
obeisty
fatty liver
drugs
against fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002367431A
Inventor
Nozomu Ishida
Nobuo Kondo
Katsumi Maezono
Koji Ohsumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2002367431A1 publication Critical patent/AU2002367431A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002367431A 2001-12-28 2002-12-26 Drugs against obeisty and drugs against fatty liver Abandoned AU2002367431A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001-401413 2001-12-28
JP2001401413A JP2005194191A (en) 2001-12-28 2001-12-28 Drug against obesity and therapeutic drug for fatty liver
PCT/JP2002/013669 WO2003057255A1 (en) 2001-12-28 2002-12-26 Drugs against obeisty and drugs against fatty liver

Publications (1)

Publication Number Publication Date
AU2002367431A1 true AU2002367431A1 (en) 2003-07-24

Family

ID=19189772

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002367431A Abandoned AU2002367431A1 (en) 2001-12-28 2002-12-26 Drugs against obeisty and drugs against fatty liver

Country Status (3)

Country Link
JP (1) JP2005194191A (en)
AU (1) AU2002367431A1 (en)
WO (1) WO2003057255A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
EP2351743A4 (en) * 2008-10-27 2012-05-09 Takeda Pharmaceutical Bicyclic compound
WO2012108478A1 (en) * 2011-02-09 2012-08-16 武田薬品工業株式会社 Monocyclic compound
AU2014236719B2 (en) * 2013-03-15 2018-06-21 The California Institute For Biomedical Research Compounds and methods for inducing chondrogenesis
EP3043800A1 (en) 2013-09-12 2016-07-20 Pfizer Inc. Use of acetyl-coa carboxylase inhibitors for treating acne vulgaris

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59164716A (en) * 1983-03-09 1984-09-17 Mitsubishi Chem Ind Ltd Biosynthetic inhibitor for fatty acid
JPH11171856A (en) * 1997-09-26 1999-06-29 Fujirebio Inc Acylsulfonamide derivative
AU2001267878A1 (en) * 2000-07-05 2002-01-14 Ajinomoto Co. Inc. Hypoglycemics
EP1316548A4 (en) * 2000-07-05 2004-05-19 Ajinomoto Kk Acylsulfonamide derivatives

Also Published As

Publication number Publication date
JP2005194191A (en) 2005-07-21
WO2003057255A1 (en) 2003-07-17

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001294808A1 (en) Catecholamine pharmaceutical compositions and methods
AU2002306269A1 (en) N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002351764A1 (en) Flavonoid compounds and their pharmaceutical uses
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU4834200A (en) Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002359694A1 (en) Compounds and methods
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2002367431A1 (en) Drugs against obeisty and drugs against fatty liver
AU2002338989A1 (en) Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine derivatives
AU4543500A (en) Pharmaceutical compositions and uses
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2002349129A1 (en) Lipid structures and uses thereof
AU5893001A (en) Top support assembly and support member
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AU2002311196B2 (en) Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
AU2002313180A1 (en) Lipid lowering composition comprising carnitine and phytosterol
AU2002305940A1 (en) Neuroprotectants formulations and methods
AU2002247222A1 (en) (z)-styrylbenzylsulfones and pharmaceutical uses thereof
AU2002245959A1 (en) An antioxidant composition and a cosmetic or pharmaceutical composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载